Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Events

Events

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • Events
  • General
  • News

Biogen And Eisai To Present ADUHELM Data At Alzheimer’s Association International Conference 2021

By Bill Haddad
Today, 11:40 PM
Item-level analysis from EMERGE trial shows consistency in slowing decline across cognitive, functional and behavioral measures in early Alzheimer's disease Presentations include an assessment of the

BIIB

Read More
1 minute read
  • Biotech
  • Events
  • General
  • News

Atreca To Host Webcast Presentation Of Initial Clinical Data From Phase 1b Trial Of ATRC-101 Jul. 29

By Bill Haddad
Today, 11:40 PM
Atreca, Inc. (Atreca) (NASDAQ:BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune

BCEL

Read More
3 minute read
  • Biotech
  • Events
  • General
  • News

Biogen And Ionis Highlight Presentation Of Topline Data From Phase 1b Study Of BIIB080/IONIS-MAPTRx Showing Drug Met Safety And Tolerability Objective At AAIC

By Bill Haddad
Today, 11:40 PM
 Biogen Inc. (NASDAQ:BIIB) and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) announced today that topline data from a Phase 1b placebo-controlled, multiple ascending dose clinical study showed that

BIIB

Read More
1 minute read
  • Events
  • FDA
  • News

UPDATE: Synaptogenix Will Hold Conference Call July 26 At 4:15 p.m. EDT To Discuss Bryostatin Trial Analyses

By Benzinga Newsdesk
Today, 11:40 PM
Also, as previously announced, Synaptogenix will hold a conference call for investors to discuss its abstract. The call will take place, today, Monday, July 26th at 4:15pm ET and will be hosted by the

SNPX

Read More
3 minute read
  • Biotech
  • Events
  • General
  • News

Prothena Highlights Presentation Of New Data From Alzheimer’s Portfolio At Alzheimer’s Association International Conference 2021

By Bill Haddad
Today, 11:40 PM
Late-breaking PRX012 poster highlights significant ex vivo clearance of both pyroglutamate-modified and -unmodified Aβ plaque from AD brain at concentrations expected to be reached in CNS with

PRTA

Read More
2 minute read
  • Events
  • News
  • Tech

Elon Musk Says Norway Has Played ‘Major Role’ In Supporting Advent Of Electric Vehicles

By Madhukumar Warrier
Today, 11:40 PM
Tesla Inc. CEO (NASDAQ: TSLA) Elon Musk has praised Norway for playing a "major role" in supporting the advent of electric vehicles.

NIO

Read More
2 minute read
  • Events
  • Media
  • News
  • Tech

Apple Supplier TSMC Explores Making First EU Chip Plant In Germany

By Rachit Vats
Today, 11:40 PM
Apple Inc (NASDAQ: AAPL) chip supplier Taiwan Semiconductor Manufacturing Co Ltd (NYSE: TSM) said on Monday it is in early-stage talks to build the company’s first semiconductor factory in Europe, Reuters

AAPL

Read More
2 minute read
  • Events
  • Media
  • News
  • Tech

Apple Will Need To Give In To Employee Demands For More Permissive Remote Work Options Or ‘Risk Losing Talent:’ Gurman

By Shivdeep Dhaliwal
Today, 11:40 PM
Apple Inc (NASDAQ: AAPL) will need to give in to “more permissive remote work” options or risk the exodus of its workforce, as per Bloomberg journalist Mark Gurman.

AAPL

Read More
2 minute read
  • Cryptocurrency
  • Events
  • Exclusives
  • Markets
  • News
  • Top Stories
  • Trading Ideas

EXCLUSIVE: Dogepalooza Is Coming In 2021 And Here’s What We Know About The Can’t-Miss Dogecoin Event

By Chris Katje
Today, 11:40 PM
A highly anticipated festival-like gathering of fans and community supporters of Dogecoin (CRYPTO: DOGE) has announced its initial details including date, location and some event highlights.

TSLA

Read More
1 minute read
  • Economics
  • Events
  • General
  • News
  • Sports

Who Wins When The Olympics Come Around? Not The Local Economy

By Sam Corey
Today, 11:40 PM
The Olympics are a time for celebration: the best athletes in the world competing and representing their nation for the top spot in their sport. But are the games an opportunity for investment? A report from the Council on Foreign Relations says no.

CMCSA

Posts navigation

Previous 1 … 150 151 152 … 165 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service